Cardiff Oncology Inc.

NASDAQ: CRDF · Real-Time Price · USD
2.44
0.00 (0.00%)
At close: Aug 15, 2025, 1:09 PM

Cardiff Oncology Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-4.55 -1.6 -1.63 -8.46
PEG Ratio
-2.12 -0.2 -0.08 0.37
PS Ratio
302.78 135.50 158.13 653.40
PB Ratio
2.49 0.95 0.57 1.67
P/FCF Ratio
-5.47 -2.1 -1.76 -10.09
P/OCF Ratio
-5.49 -2.14 -1.8 -10.18
OCF/S Ratio
-55.19 -63.29 -87.62 -64.18
Debt / Equity Ratio
0.02 0.03 0.03 0.02
Quick Ratio
7.08 7.41 14.25 22.28
Current Ratio
7.08 7.41 14.25 22.28
Asset Turnover
0.01 0.01 0.00 0.00
Interest Coverage
n/a n/a n/a n/a
Return on Equity
-0.55 -0.59 -0.35 -0.2
Return on Assets
-0.47 -0.51 -0.32 -0.19
Return on Invested Capital
-0.58 -0.63 -0.35 -0.2
Dividend Yield
n/a n/a 0.01 0.00
Payout Ratio
n/a n/a -0.01 -0.00
Gross Profit Margin
1.00 1.00 0.48 -0.39
Net Profit Margin
-66.52 -84.92 -97.17 -77.28
Pretax Profit Margin
-66.55 -84.92 -100.27 -78.81
Operating Profit Margin
-71.23 -93.06 -103.37 -80.38
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-70.64 -92.24 -102.76 -79.12